An FDA warning covers Ozempic, Mounjaro and other GLP-1 drugs over a rare optic nerve condition. How high is the risk, and when is an urgent eye exam needed?US Warns Of Vision Loss Risk With Type 2 Diabetes And Weight-Loss Drugs